In this Session, Acacia Parks, regulatory consultant and former Chief Science Officer at Happify Health, walked through the changing regulation of digital mental health products. She focused on the FDA’s TEMPO programme and what it means for companies in the field.

Speakers

Acacia Parks

Speaker · Scientific and Regulatory Consultant; former Chief Science Officer, Happify Health

What you will learn:

  • How FDA expectations changed after the “Wild West” years of 2011 to 2016.

  • Which regulatory challenges digital mental health companies face today.

  • What the TEMPO programme offers, and how it connects to ACCESS and value-based care.

  • Where enforcement discretion leaves products in a grey zone.

  • How state-level AI regulation and the federal response affect your product.

  • What it takes to apply for TEMPO.

Hemingway Pro · Session Recap

Read the full recap

Full Session notes and resources are for Hemingway Pro members.

Already a member? Sign in · See standard plans

Keep reading